Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIF 1149 BS in Healthy Male Volunteers
NCT02203487Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 1999
- Primary completion
- Jun 2000
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in asthma and allergic rhinitis (AR) comparing BIIF 1149 BS with Placebo (2 arms). Primary endpoints: Number of subjects with adverse events at 55 days, Number of subjects with abnormal changes in laboratory parameters and 1 more. Started Nov 1999; status: completed.
02
Drugs
figopitant
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02203487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203487.